HomeGeneticsConditionOphthalmo-acromelic syndrome
Back to Condition
Ophthalmo-acromelic syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Ophthalmo-acromelic syndrome

Ophthalmo-acromelic syndrome is a rare condition present from birth that causes malformations of the eyes, hands, and feet.

Overview

Ophthalmo-acromelic syndrome is a condition that results in malformations of the eyes, hands, and feet. The features of this condition are present from birth. The eyes are often absent or severely underdeveloped (anophthalmia), or they may be abnormally small (microphthalmia). Usually both eyes are similarly affected in this condition, but if only one eye is small or missing, the other eye may have a defect such as a gap or split in its structures (coloboma).

The most common hand and foot malformation seen in ophthalmo-acromelic syndrome is missing fingers or toes (oligodactyly). Other frequent malformations include fingers or toes that are fused together (syndactyly) or extra fingers or toes. These skeletal malformations are often described as acromelic, meaning that they occur in the bones that are away from the center of the body. Additional skeletal abnormalities involving the long bones of the arms and legs or the spinal bones can also occur. Affected individuals may have distinctive facial features, an opening in the lip with or without an opening in the roof of the mouth, or intellectual disability.

Frequency

The prevalence of ophthalmo-acromelic syndrome is not known; approximately 35 cases have been reported in the medical literature.

Causes

Mutations in the SMOC1 gene cause ophthalmo-acromelic syndrome. The SMOC1 gene provides instructions for making a protein called secreted modular calcium-binding protein 1 (SMOC-1). This protein is found in basement membranes, which are thin, sheet-like structures that support cells in many tissues and help anchor cells to one another during embryonic development. The SMOC-1 protein attaches (binds) to many different proteins and is thought to regulate molecules called growth factors that stimulate the growth and development of tissues throughout the body. These growth factors play important roles in skeletal formation, normal shaping (patterning) of the limbs, as well as eye formation and development. The SMOC-1 protein also likely promotes the maturation (differentiation) of cells that build bones, called osteoblasts.

SMOC1 gene mutations often result in a nonfunctional SMOC-1 protein. The loss of SMOC-1 could disrupt growth factor signaling, which would impair the normal development of the skeleton, limbs, and eyes. These changes likely underlie the anophthalmia and skeletal malformations of ophthalmo-acromelic syndrome. It is unclear how SMOC1 gene mutations lead to the other features of this condition.

Some people with ophthalmo-acromelic syndrome do not have an identified mutation in the SMOC1 gene. The cause of the condition in these individuals is unknown.

Gene Associated with Ophthalmo-acromelic Syndrome

  • SMOC1

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Frequently Asked Questions

Yes. Approximately one‑third of affected individuals have intellectual disability or developmental delays. Early developmental screening, speech and occupational therapy, and individualized education plans are recommended to address potential learning or motor challenges.
Surgery is usually planned between ages 6 months and 3 years, once the child’s growth allows safe manipulation of small bones. Common procedures include syndactyly release, toe or finger reconstruction, and, in cases of oligodactyly, toe‑to‑hand transfers or prosthetic fitting. Multidisciplinary discussion with orthopedic, plastic, and hand surgeons guides timing.
Diagnosis combines a detailed physical exam (noting anophthalmia/microphthalmia and hand/foot anomalies) with imaging studies of the eyes and limbs, followed by molecular genetic testing that identifies pathogenic variants in the SMOC1 gene.
Early visual rehabilitation includes fitting a custom ocular prosthesis or a conformer to promote orbital growth, low‑vision therapy, and, when possible, surgical enlargement of the globe. Enrolling the child in a visual stimulation program and regular ophthalmology follow‑up are essential.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA